Caricamento...
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY
Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...
Salvato in:
| Pubblicato in: | Acta Endocrinol (Buchar) |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Acta Endocrinologica Foundation
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/ https://ncbi.nlm.nih.gov/pubmed/31149244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|